Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia
Status:
Terminated
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to study the effect of eltrombopag on chemotherapy induced
thrombocytopenia. Thrombocytopenia is when there is a low number of platelets in the blood.
Sometimes, thrombocytopenia occurs as a side effect of chemotherapy treatments.